6-KThe Wire
YD Bio Ltd files 6-K
Filed Jan 21, 2026 · 6mo ago · Accession 0001213900-26-005858
Plain English
YD Bio Limited announced the appointment of new directors to its Board committees and that it has regained compliance with Nasdaq's Audit Committee requirements.
Filing details
- Company
- YD Bio Ltd
- Ticker
- YDES
- CIK
- 2011674
- Form type
- 6-K
- Filing date
- Jan 21, 2026
- Report date
- Jan 21, 2026
- Document
- ea0273361-6k_ydbio.htm
- Size
- 13 KB